619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results

• Shivaani Kummar,
• Drew Rasco,
• Scott A Laurie,
• Dylan M Glatt,
• Sophia R Majeed,
• Albiruni Abdul Razak,
• Anh Diep

Affiliations

Shivaani Kummar

5Oregon Health and Science University, Portland, OR, USA, Portland, OR, USA

Drew Rasco

23START, San Antonio, TX, USA

Scott A Laurie

2The Ottawa Hospital Cancer Center, Ottawa, ON, Canada

Dylan M Glatt

23andMe Inc., South San Francisco, CA, USA

Sophia R Majeed

23andMe Inc., South San Francisco, CA, USA

Albiruni Abdul Razak

2University Health Network, Toronto, ON, Canada

Anh Diep

423andMe, South San Francisco, CA, USA